DEVELOPMENT, VALIDATION AND RESOLVING MASS BALANCE ISSUE BY USING ALTERNATIVE OXIDIZING REAGENTS FOR THE DETERMINATION OF METFORMIN HYDROCHLORIDE IMPURITIES IN API AND PHARMACEUTICAL DOSAGE FORMS
Abstract
A novel, sensitive, stability indicating RP-HPLC method has been developed for the quantitative estimation of Metformin Hydrochloride impurities in both bulk drugs and pharmaceutical dosage forms. Effective chromatographic separation was achieved on a C8 stationary phase with simple mobile phase combination delivered in a isocratic mode and quantitation was by ultraviolet detection at 218 nm. The mobile phase consists mixture of buffer and methanol delivered at a flow rate of 1.0 ml/min. Regression analysis showed an r value (correlation coefficient) grater than 0.999 for Metformin Hydrochloride and its impurities. Mass balance issue was observed in peroxide stress and resolved by using alternative oxidizing reagents. The developed method was validated as per ICH guidelines and found to be linear, accurate, precise, specific, robust and rugged.
Keywords: Metformin Hydrochloride, Impurities, Validation, RP-HPLC, ICH guidelinesDownloads
References
Klepser TB, Kelly MW. Metformin hydrochloride: an antihyperglycermic agent.
Am J Health System Pharm 1997; 54: 893–903.
Hitt E. Uses of Metformin may extend beyond patients with type 2 diabetes.
Drugs 1995; 63: 1879–1894.
Gorog S. Identification and Determination of impurities in Drugs.
Talanta 1997; 44: 1517 –1526.
Sanjay BB, Bharati RK, Yogini SJ, Atul AS. Impurity profile: Significance in active pharmaceutical ingredient. Eurasian J Anal Chem 2007; 2: 32 –53.
ICH, Q3A (R2). Impurities in New Drug Substances, International Conference on Harmonization, 2006.
ICH, Q3B (R2). Impurities in New Drug Products, International Conference on Harmonization, 2006.
European Pharmacopeia. 01/2008:0931; 7.0: 2458-2459.
Indian Pharmacopoeia, Government of India, Ministry of wealth and family welfare. The Controller of publication, New Delhi. 2010; p 1657-1659.
The United States Pharmacopeia. USP35-NF30: 3829-3837.
Narendra kumar T, Chandra Mohan Rao K, Sreenivasulu R, Raju NSV, Viswanath Reddy P. Novel RP-HPLC method for the estimation of Metformin Hydrochloride in pharmaceutical dosage forms. IJSID 2001; 1: 395-421.
Malleswararao CHSN, Suryanarayana MV, Mukkanti K. Simultaneous Determination of Sitagliptin Phosphate Monohydrate and Metformin Hydrochloride in Tablets by a Validated UPLC Method. Sci Pharm 2012; 80: 139–152.
Rani Sirisha G, Vasanth PM, Ramesh T, Ramesh M. RP-HPLC method development and validation for simultaneous estimation of Metformin and Sitagliptin in tablet dosage forms. IJPRA 2013; 3: 8-12.
Govindasamy Jeyabalan, Narendra Nyola. Simultaneous estimation of Sitagliptin phosphate monohydrate and metformin hydrochloride in bulk and pharmaceutical formulation by RP-HPLC. J Pharm Educ Res 2012; 3: 24-28.
Gabriela K, Elzbieta LA. Determination of impurities in medical products containing Metformin Hydrochloride. Acta Pol Pharm 2010; 67: 593-598.
Victor David, Andrei Medvedovici, Florin Albu. Retention Behavior of Metformin and Related Impurities in Ionâ€Pairing Liquid Chromatography. J Liq Chromatogr R T 2005; 28: 81-95.
Rajagopalan R. Review of Regulatory Guidance on Impurities. Sep Sci Technol 2004; 5: 27-37.
ICH, Q2 (R1). Validation of Analytical Procedures: Text and Methodology, International Conference on Harmonization, 2005.
ICH, Q1A (R2). Stability Testing of New Drug Substances and Products, International Conference on Harmonization, 2003.
ICH, Q1B. Photo Stability Testing of New Drug Substances and Products, International Conference on Harmonization, 1996
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.